Abstract
Chemotactic cytokines, or chemokines, are a large family of small proteins, which are distinguished from other cytokines in that they are the only members of the cytokine family that act on G-protein coupled receptor superfamily. This minireview tries to answer the title question by structure/function analysis of chemokines, cytokines, and their receptors. We also consider secretion of chemokines/ cytokines in health and disease as well as expression of their receptors both in immune system and brain. Our analysis suggests that cytokine and chemokine receptors may share similar architecture with Toll-like receptors. Such similarity hints a similar way of their functioning as molecular switches controlled by protein-protein interactions. Hence, we pay attention to the related receptor-receptor associations and evolutionary conserved leucine-rich motifs.
Keywords: Leucine-rich motif, protein-protein interaction, Toll-like receptor
Current Medicinal Chemistry
Title: Why Chemokines are Cytokines while their Receptors are not Cytokine Ones?
Volume: 15 Issue: 13
Author(s): Larisa B. Goncharova and Alexander O. Tarakanov
Affiliation:
Keywords: Leucine-rich motif, protein-protein interaction, Toll-like receptor
Abstract: Chemotactic cytokines, or chemokines, are a large family of small proteins, which are distinguished from other cytokines in that they are the only members of the cytokine family that act on G-protein coupled receptor superfamily. This minireview tries to answer the title question by structure/function analysis of chemokines, cytokines, and their receptors. We also consider secretion of chemokines/ cytokines in health and disease as well as expression of their receptors both in immune system and brain. Our analysis suggests that cytokine and chemokine receptors may share similar architecture with Toll-like receptors. Such similarity hints a similar way of their functioning as molecular switches controlled by protein-protein interactions. Hence, we pay attention to the related receptor-receptor associations and evolutionary conserved leucine-rich motifs.
Export Options
About this article
Cite this article as:
Goncharova B. Larisa and Tarakanov O. Alexander, Why Chemokines are Cytokines while their Receptors are not Cytokine Ones?, Current Medicinal Chemistry 2008; 15 (13) . https://dx.doi.org/10.2174/092986708784535009
DOI https://dx.doi.org/10.2174/092986708784535009 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Airway Obstruction in a Cancer Patient: Is it Always Cancer?
Current Respiratory Medicine Reviews Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis
Current Pharmaceutical Design Current Opinion on 3-[2-[(2-Tert-Butyl-Phenylaminooxalyl)-Amino]-Propionylamino]- 4-Oxo-5-(2,3,5,6-Tetrafluoro-Phenoxy)-Pentanoic Acid, an Investigational Drug Targeting Caspases and Caspase-Like Proteases: The Clinical Trials in Sight and Recent Anti-Inflammatory Advances
Recent Patents on Inflammation & Allergy Drug Discovery Patents in Diagnosis of Preeclampsia
Recent Patents on Biomarkers Regulation of T Cell Signaling and Function by Cbl-b
Current Immunology Reviews (Discontinued) New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments
Letters in Drug Design & Discovery Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins
Anti-Cancer Agents in Medicinal Chemistry Identification of Potential Drug Therapy for Dermatofibrosarcoma Protuberans with Bioinformatics and Deep Learning Technology
Current Computer-Aided Drug Design Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Citrus Flavonoids and the Prevention of Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases – Part I
Current Medicinal Chemistry Cell-based Assays for Assessing Toxicity: A Basic Guide
Medicinal Chemistry Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Methodological Issues of Clinical Research with EGFR Inhibitors
Current Cancer Therapy Reviews Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics
Current Cancer Drug Targets Albumin Induces Neuroprotection Against Ischemic Stroke by Altering Toll-Like Receptor 4 and Regulatory T Cells in Mice
CNS & Neurological Disorders - Drug Targets The Antiprogestogen Mifepristone: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update
Current Medicinal Chemistry Fight Against H1N1 Influenza A Virus: Recent Insights Towards the Development of Druggable Compounds
Current Medicinal Chemistry